330792-68-2

Basic information

• Product Name: Propanedinitrile, 2-[hydroxy(4-phenoxyphenyl)Methylene]-
• Synonyms: Propanedinitrile, 2-[hydroxy(4-phenoxyphenyl)Methylene]-;2-[Hydroxy-(4-phenoxy-phenyl)-Methylene]-Malononitrile;Propanedinitrile, 2-[hydroxy(4-phenoxyphenyl)Methylene]- 2-[Hydroxy-(4-phenoxy-phenyl)-Methylene]-Malononitrile
• CAS NO: 330792-68-2
• Molecular Formula: C₁₆H₁₀N₂O₂
• Molecular Weight: 262.2628
• Mol File: 330792-68-2.mol
• Article Data: 39

Chemical Properties

• Boiling Point: 415.3±45.0 °C(Predicted)
• Appearance: /
• Density: 1.279±0.06 g/cm3(Predicted)
• PKA: 4.65±0.50(Predicted)
• CAS DataBase Reference: Propanedinitrile, 2-[hydroxy(4-phenoxyphenyl)Methylene]-(CAS DataBase Reference)
• NIST Chemistry Reference: Propanedinitrile, 2-[hydroxy(4-phenoxyphenyl)Methylene]-(330792-68-2)
• EPA Substance Registry System: Propanedinitrile, 2-[hydroxy(4-phenoxyphenyl)Methylene]-(330792-68-2)

Safety Data

• Hazardous Substances Data: 330792-68-2(Hazardous Substances Data)

Usage

General Description

Propanedinitrile, 2-[hydroxy(4-phenoxyphenyl)methylene]- is a synthetic chemical compound commonly used in various industrial applications. It contains various chemical groups including a hydroxy group, a phenoxyphenyl group, and a methylene group attached to a propanedinitrile structure. Its unique chemical structure makes it useful in a variety of chemical reactions and processes. The specific properties like molecular weight, boiling point, melting point, and other physical and chemical properties of this compound will largely depend upon its precise molecular structure and the conditions under which it is used or stored. It is important to handle this and other industrial chemicals with care to protect human health and the environment.

Upstream product

• 2215-77-2 4-Phenoxybenzoic acid 
• 459-57-4 4-fluorobenzaldehyde 
• 108-95-2 phenol 
• 619-44-3 methyl 4-iodobenzoate 
• 21218-94-0 methyl 4-phenoxybenzoate 
• 109-77-3 malononitrile 
• 1623-95-6 4-phenoxybenzoyl chloride 

Downstream Products

• 330792-69-3 2-[(4-phenoxy-phenyl)-methoxy-methylene]-malononitrile 
• 1609467-43-7 benzyl 3-[5-amino-4-cyano-3-(4-phenoxy-phenyl)-pyrazol-1-yl]-piperidine-1-carboxylate 
• 1609467-44-8 5-amino-3-(4-phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazole-4-carbonitrile 
• 1609467-45-9 5-amino-3-(4-phenoxyphenyl)-1-piperidin-3-yl-1H-pyrazole-4-carboxylic acid amide 
• 1609465-64-6 5-amino-1-(1-cyanopiperidin-3-yl)-3-(4-phenoxyphenyl)-1H-pyrazole carboxamide 
• 1609468-23-6 (S)-5-amino-3-(4-phenoxyphenyl)-1-piperidin-3-yl-1H-pyrazole-4-carboxylic acid amide 
• 1609467-02-8 1-[(3S)-1-acryloylpiperidin-3-yl]-5-amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carboxamide 
• 1558038-42-8 (R)-5-amino-3-(4-phenoxyphenyl)-1-piperidin-3-yl-1H-pyrazole-4-carboxylic acid amide 
• 1558036-85-3 1-[(3R)-1-acryloylpiperidin-3-yl]-5-amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carboxamide 
• 1609467-03-9 5-amino-1-{1-[(2E)-but-2-enoyl]piperidin-3-yl}-3-(4-phenoxyphenyl)-1H-pyrazole-4-carboxamide 
• 1609467-04-0 5-amino-1-{(3R)-1-[(2E)-4-hydroxybut-2-enoyl]piperidin-3-yl}-3-(4-phenoxyphenyl)-1H-pyrazole-4-carboxamide 
• 1609465-65-7 5-amino-1-[(3R)-1-cyanopiperidin-3-yl]-3-(4-phenoxyphenyl)-1H-pyrazole-4-carboxamide 
• 1609465-66-8 5-amino-1-[(3S)-1-cyanopiperidin-3-yl]-3-(4-phenoxyphenyl)-1H-pyrazole-4-carboxamide 
• 1609465-67-9 5-amino-1-[1-(cyanomethyl)piperidin-3-yl]-3-(4-phenoxyphenyl)-1H-pyrazole-4-carboxamide 

Relevant articles and documents

PROCESSES AND INTERMEDIATES FOR PREPARING A BTK INHIBITOR

Disclosed is a process for the preparation of certain intermediates, e.g. process for preparing a compound of formula (I) or a pharmaceutically acceptable salt thereof, in an enantioenriched form, which intermediate and processes are useful in the preparation of a BTK inhibitor, such as ibrutinib.

TREATMENT OF INDOLENT OR AGGRESSIVE B-CELL LYMPHOMAS USING A COMBINATION COMPRISING BTK INHIBITORS

Disclosed herein is a method for the prevention, delay of progression or treatment of indolent or aggressive B-cell lymphomas in an individual in need thereof, comprising administering a Btk inhibitor (in particularly (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo-[1,5-a]pyrimidine-3-carboxamide or a pharmaceutically acceptable salt thereof) in combination with an anti-PD-1 antibody. The potent and selective BTK inhibitor in combination with the anti-PD-1 antibody have a manageable toxicity profile in patients with indolent and aggressive lymphomas.

Method for preparing ibrutinib

The invention discloses a method for preparing ibrutinib. The method includes the following steps of 1, preparation of IB-A, 2, preparation of IB-B, 3, preparation of IB-C, 4, preparation of IB-D, 5,preparation of IB-E, 6, preparation of IB-F, 7, preparation of IB-G, 8, preparation of IB-H, and 9, preparation of IB-J. The method has the advantages that the process is mature and stable, the quality of the product is stable, the production process is safe and reliable, and the ibrutinib is suitable for industrial production.